Lupin Ltd. | Mutual Funds
Mutual Funds that own Lupin Ltd.
Government Pension Fund - Global (The)
5,566,688
1.23%
4,250,038
0.01%
12/31/2017
Comgest Growth Plc - Emerging Markets
5,234,463
1.15%
702,850
1.04%
05/31/2018
Emerging Markets Fund of the Genesis Group Trust for Employee
4,424,830
0.98%
89,435
0.69%
12/31/2016
ICICI Prudential Tax Plan
3,696,402
0.82%
2,370,650
5.98%
08/31/2018
Vanguard Emerging Markets Stock Index Fund
3,528,076
0.78%
-25,760
0.06%
07/31/2018
American Funds Capital World Growth & Income Fund
3,216,144
0.71%
3,216,144
0.05%
06/30/2018
Magellan
3,206,175
0.71%
420,434
1.09%
05/31/2018
Vanguard Total International Stock Index Fund
3,137,658
0.69%
0
0.01%
07/31/2018
Franklin India Prima Plus
2,800,000
0.62%
-100,000
2.12%
08/31/2018
Caisse de Dépôt & Placement du Québec
2,326,461
0.52%
1,449,376
0.01%
12/31/2017
| Address |
B/4 Laxmi Towers
Mumbai Maharashtra 400051
India
|
|
Employees
|
- |
| Website |
http://www.lupinworld.com |
| Updated |
09/14/2018 |
| Lupin Ltd. engages in the manufacture of pharmaceutical products. Its offers branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The firm caters to the cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives, nonsteroidal anti-inflammatory drug therapy, anti-tuberculosis, and cephalosporins industry segments. |
